ECOG-ACRIN A Randomized Phase II Trial of Cabozantinib and Cabozantinib Plus Nivolumab Versus Standard Chemotherapy in Patients with Previously Treated Non-Squamous NSCLC Adult CIRB - Late Phase Emphasis Active Available to Open